Patents by Inventor Robert Alfonso Lasser

Robert Alfonso Lasser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230018765
    Abstract: Provided herein are methods for treating depression, such as major depressive disorder, in a subject in need thereof, comprising administering to the subject an effective amount of Compound 1 or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 5, 2020
    Publication date: January 19, 2023
    Inventors: Stephen Jay Kanes, James Doherty, Handan Gunduz-Bruce, Jeffrey Martin Jonas, Robert Alfonso Lasser
  • Publication number: 20220323462
    Abstract: Provided herein are methods for treating depression, such as postpartum depression or major depressive disorder, in a subject in need thereof, comprising administering to the subject an effective amount of Compound 1 or a pharmaceutically acceptable salt thereof:
    Type: Application
    Filed: June 17, 2022
    Publication date: October 13, 2022
    Inventors: Stephen Jay Kanes, James J. Doherty, Handan Gunduz-Bruce, Jeffrey M. Jonas, Robert Alfonso Lasser
  • Publication number: 20210338692
    Abstract: Provided herein are methods for treating depression, such as postpartum depression or major depressive disorder, in a subject in need thereof, comprising administering to the subject an effective amount of Compound 1 or a pharmaceutically acceptable salt thereof: (Compound I).
    Type: Application
    Filed: June 12, 2019
    Publication date: November 4, 2021
    Inventors: Stephen Jay KANES, James J. DOHERTY, Handan GUNDUZ-BRUCE, Jeffrey M. JONAS, Robert Alfonso LASSER
  • Publication number: 20200113917
    Abstract: Provided herein are methods for treating depression, such as postpartum depression or major depressive disorder, in a subject in need thereof, comprising administering to the subject an effective amount of Compound 1 or a pharmaceutically acceptable salt thereof:
    Type: Application
    Filed: December 5, 2019
    Publication date: April 16, 2020
    Inventors: Stephen Jay Kanes, James J. Doherty, Handan Gunduz-Bruce, Jeffrey M. Jonas, Robert Alfonso Lasser